It is the design of your study that will give it credence in the wider scientific community. If it is clear from the dissemination of the study that there has not been a clear hypothesis, endpoints are inappropriate and the study design inadequate, then it is unlikely that the outcome of the study will be used to contribute to the process of regulatory approval, or form part of a meta-analysis. It is important to get the design right from the start. The time taken will be well worth it.
KeywordsVertebral Fracture Postmenopausal Osteoporosis Regulatory Approval Equivalence Trial Broadband Ultrasound Attenuation
Unable to display preview. Download preview PDF.
- 1.Guidelines for the Preclinical and Clinical Evaluation of Agents used in the Prevention or Treatment of Postmenopausal Osteoporosis. FDA, 1994 (http://www.fda.gov/cder/guidance/osteo.pdf).
- 2.Deeks J, Glanville J, Sheldon T. Undertaking Systematic Reviews of Research on Effectiveness. CRD Report 4, NHS Centre for Reviews and Dissemination, University of York, 1996.Google Scholar
- 6.Notes for Guidance on Postmenopausal Osteoporosis in Women. Committee for Proprietary Medicinal Products (CPMP), 2001 (http://www.emea.eu.int/pdfs/human/ewp/055295en.pdf).
- 13.Lips P, Cooper C, Agnusdei D et al. Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int 1999; 10: 150–60.PubMedCrossRefGoogle Scholar
- 17.Pocock SJ Clinical Trials: A Practical Approach. Chichester: John Wiley & Sons. 1983.Google Scholar
- 18.International Conference on Harmonization: Guidance on Statistical Principles for Clinical Trials. Federal Register 1998;63:49583–98. (Available at http://www.fda.gov/cder/guidance/91698.pdf)Google Scholar
- 19.Kim. JS. Determining Sample Size for Testing Equivalence. Medical Device and Diagnostic Industry. May 1997:114–117. (Available at http://www.devicelink.com/mddi/archive/97/05/ 020.html)Google Scholar
- 26.Stewart AF, Cain RL, Burr DB, Jacob D, Turner CH, Hock JM. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1–34, parathyroid hormone-related protein 1–36, and SDZ-parathyroid hormone 893. J Bone Miner Res 2000; 15: 1517–25.PubMedCrossRefGoogle Scholar
- 29.ICH Harmonized Tripartite Guideline E6 Good Clinical Practice: Consolidated Guidance (http://www.fda.gov/cder/guidance/959fnl.pdf).
- 30.Rice PL, Ezzy D. Qualitative Research Methods: A Health Focus. Oxford University Press, 1999.Google Scholar
- 31.Holloway W, Jefferson T. Doing Qualitative Research Differently. London. Sage Publications, 2000.Google Scholar